
AI agent teams accelerate scientific discovery
Two AI-agent systems described in Nature—Google DeepMind's Co-Scientist and FutureHouse's Robin—use teams of AI to generate hypotheses, pick experiments, and analyze data to speed up early drug-discovery work. In initial tests they proposed plausible repurposing candidates for AML and dry AMD, with humans carrying out the experiments and validating results; while promising, most candidates require further validation in broader use.












